These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14962962)

  • 41. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.
    Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Kerstens PJ; Nielen MM; Vos K; van Schaardenburg D; Speyer I; Seys PE; Breedveld FC; Allaart CF; Dijkmans BA
    Ann Rheum Dis; 2010 Jan; 69(1):65-9. PubMed ID: 19155234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
    Hashimoto J; Garnero P; van der Heijde D; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Yoshikawa H; Nishimoto N
    Mod Rheumatol; 2009; 19(3):273-82. PubMed ID: 19452245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry.
    Ornbjerg LM; Ostergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Ringsdal VS; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Dencker D; Hansen A; Andersen AR; Hetland ML
    Ann Rheum Dis; 2013 Jan; 72(1):57-63. PubMed ID: 22532636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.
    Constantin A; Lauwers-Cancès V; Navaux F; Abbal M; van Meerwijk J; Mazières B; Cambon-Thomsen A; Cantagrel A
    Arthritis Rheum; 2002 Jul; 46(7):1754-62. PubMed ID: 12124858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
    Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
    Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
    Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.
    Finckh A; Choi HK; Wolfe F
    Ann Rheum Dis; 2006 Sep; 65(9):1192-7. PubMed ID: 16540549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
    González-Gay MA; Hajeer AH; García-Porrúa C; Dababneh A; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection.
    Mewar D; Marinou I; Coote AL; Moore DJ; Akil M; Smillie D; Dickson MC; Binks MH; Montgomery DS; Wilson AG
    Ann Rheum Dis; 2008 Jul; 67(7):980-3. PubMed ID: 17901090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis.
    Laivoranta-Nyman S; Möttönen T; Hannonen P; Korpela M; Kautiainen H; Leirisalo-Repo M; Julkunen H; Luukkainen R; Hakala M; Vuori K; Laine AP; Toivanen A; Ilonen J;
    Clin Exp Rheumatol; 2006; 24(6):636-42. PubMed ID: 17207378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
    Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Pettersson IF; van Vollenhoven RF
    Ann Rheum Dis; 2012 Feb; 71(2):186-91. PubMed ID: 21930734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression.
    Stenger AA; Van Leeuwen MA; Houtman PM; Bruyn GA; Speerstra F; Barendsen BC; Velthuysen E; van Rijswijk MH
    Br J Rheumatol; 1998 Nov; 37(11):1157-63. PubMed ID: 9851262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.
    Fedele AL; Petricca L; Tolusso B; Alivernini S; Canestri S; Di Mario C; Bosello SL; Ferraccioli G; Gremese E
    Scand J Rheumatol; 2018 Sep; 47(5):351-359. PubMed ID: 29542372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
    Scott DL; Smolen JS; Kalden JR; van de Putte LB; Larsen A; Kvien TK; Schattenkirchner M; Nash P; Oed C; Loew-Friedrich I;
    Ann Rheum Dis; 2001 Oct; 60(10):913-23. PubMed ID: 11557646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.
    Kyburz D; Gabay C; Michel BA; Finckh A;
    Rheumatology (Oxford); 2011 Jun; 50(6):1106-10. PubMed ID: 21258051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.